Molecular tests for colorectal cancer screening.

Area of Science:

• Oncology
• Molecular Diagnostics
• Gastroenterology

Background:

• Early detection of colorectal cancer (CRC) and high-risk adenomas is crucial for reducing mortality.
• Current noninvasive screening methods like fecal occult blood tests (FOBT) have limitations in accuracy.
• Molecular markers in stool and blood offer potential for more sensitive and specific CRC detection.

Purpose of the Study:

• To review the performance of DNA, RNA, and protein markers for colorectal cancer detection.
• To highlight the advancements and trends in molecular marker research for CRC screening.
• To assess the readiness of molecular markers for implementation in screening programs.

Main Methods:

• Literature review of studies evaluating DNA, RNA, and protein markers for CRC detection in stool and blood.
• Analysis of marker performance compared to existing FOBT methods.
• Identification of trends in molecular marker development, such as the shift towards methylation markers.

Main Results:

• Molecular tests, particularly DNA and protein markers, are emerging as promising alternatives to FOBT.
• Methylation markers are gaining favor over traditional mutation markers in DNA-based detection.
• Emerging protein markers show potential for improved diagnostic accuracy, often demonstrated in smaller studies.

Conclusions:

• Molecular markers hold significant promise for enhancing the accuracy and informativeness of colorectal cancer screening.
• While promising, many molecular markers require validation through large, well-controlled clinical trials.
• Successful implementation of molecular markers in screening settings hinges on robust evidence from extensive trials.